Speaker Profile
Ph.D., Research Assistant Professor, La Jolla Institute
Biography
Dr. Weiskopf, devoted her career to understanding the adaptive immune response to emerging infectious viruses relevant to human health and disease. Following her PhD, she obtained post-doctoral training at the La Jolla Institute for Immunology (LJI) where her efforts were dedicated to characterize human dengue virus-specific CD8+ and CD4+ T cell responses in samples from areas with endemic dengue infection and following experimental dengue vaccination. As a Research Assistant Professor in the Center for Infectious Diseases and Vaccine Research at LJI she have focused on the characterization of Zika and Chikungunya virus specific T cell responses and also became interested in the effects of pre-existing immunity against dengue virus to subsequent zika virus infection. Most recently she have characterized SARS-CoV-CoV-2 specific T cell responses after natural infection and vaccination. Understanding adaptive immune responses to SARS-CoV-2 is important for vaccine development efforts, interpreting disease pathogenesis, and calibration of future pandemic control measures.
Session Abstract – PMWC 2022 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
